| Gene symbol | CD79B | Synonyms | AGM6, B29, IGB, Igbeta | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q23.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD79b molecule | ||||
| GTO ID | GTC2493 |
| Trial ID | NCT04609241 |
| Disease | B-Cell Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia |
| Altered gene | CD79b |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD79b CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | CD79b-001 |
| Cohort 1 | |||||||
|
|||||||